Nabriva Therapeutics PLC (NBRVF)

[chitre]

we have to hope the vote is no


Nabriva Therapeutics (NBRV) Risk
At the end of the month (29th of July) there will be voted for a reverse split, which might decline the prices. However, I think this is to prevent delisting from stock exchange. This will be unnecessary if the stock finishes 10 days in a row above 1, which is highly possible with this Merck collab news. I expect this to be cancelled before the vote, if not, the vote will be overwhelmingly no. this rs was scheduled way before the Merck partnership was announced.